<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ROC-17010353</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-01-08</date_registration>
      <primary_sponsor> the Third Xiangya Hospital of Central South University</primary_sponsor>
      <public_title>Neuropeptide Y promotes adipogenic differentiation via the PPAR-γ pathway in primary cultured human adipose-derived stem cells</public_title>
      <acronym />
      <scientific_title>Neuropeptide Y promotes adipogenic differentiation via the PPAR-γ pathway in primary cultured human adipose-derived stem cells</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-02-01</date_enrolment>
      <type_enrolment />
      <target_size>Case series:10;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=17630</url>
      <study_type>Relative factors research</study_type>
      <study_design>Case series</study_design>
      <phase>Other</phase>
      <hc_freetext>obesity</hc_freetext>
      <i_freetext>Case series:NPY;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Pingan Hu</firstname>
        <middlename />
        <lastname />
        <address>138 Tongzipo Road, Changsha, Hunan, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15116310417</telephone>
        <email>pingan_hu123@126.com</email>
        <affiliation>the Third Xiangya Hospital of Central South University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Pingan Hu</firstname>
        <middlename />
        <lastname />
        <address>138 Tongzipo Road, Changsha, Hunan, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15116310417</telephone>
        <email>pingan_hu123@126.com</email>
        <affiliation>the Third Xiangya Hospital of Central South University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Aged less than 50 years old, no history of acute and chronic infection and malignant tumor metastasis, no history of endocrine and systemic metabolic diseases, without taking the intervention of sugar and fat metabolism of drug history, taking abdominal subcutaneous adipose tissue of about 10 grams.</inclusion_criteria>
      <agemin />
      <agemax>50</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Aged more than 50 years of age, with acute and chronic infection and malignant tumor metastasis, endocrine and systemic metabolic disease history, have taken the intervention of sugar and fat metabolism of drug history</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>adipogenesis;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Science and Technology Planning Project of Hu Nan Province, China (No. 2013SK3060)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>1990-01-01</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>